BSV to acquire Firstline Pharma and Genomicks
Following the acquisition, the two companies will be held by BSV
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Bharat Serums and Vaccines
BSV opens animal testing facility at Ambernath
The facility houses a team of highly qualified doctorates, veterinarians, biotechnologists, and biologists
BSV partners with IISc for research on next-gen snakebite therapy
Supports research of antibodies and anti-venom development at the IISc Evolutionary Venomics Laboratory facility
BSV enters into research partnership with National Chemical Laboratory, Pune
The collaboration primarily focuses on evaluation of certain recombinant cell line technologies developed by NCL for biopharma…
BSV acquires women’s health brand Tidilan
Tidilan is currently available in tablet and injectable dosage forms
SEC asks Bharat Serums to revise phase I/II trial protocols for equine antiserum to treat COVID-19
The SEC has recommended grant of permission to conduct the clinical trial provided the company submits the revised clinical trial…
GenNext at SIRO Clinpharm
SIRO, one of India’s earliest CROs, is set to scale new heights, as its next-gen leaders chart out fresh strategies to sustain its…
Equine polyclonal antibodies have shown higher potency in in-vitro studies of SARS-CoV-2 virus…
Bharat Serums and Vaccines has initiated a research project to co-develop an equine polyclonal antibody, along with NIV, against…
Cadila buys JV partner’s 50 per cent stake in Zydus BSV Pharma
Zydus BSV has now become 100 per cent subsidiary of Cadila Healthcare